SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-98718"
 

Sökning: id:"swepub:oai:DiVA.org:uu-98718" > Prolactin treatment...

Prolactin treatment improves engraftment and function of transplanted pancreatic islets

Johansson, Magnus, 1976- (författare)
Uppsala universitet,Institutionen för medicinsk cellbiologi,Per-Ola Carlsson
Olerud, Johan, 1977- (författare)
Uppsala universitet,Institutionen för medicinsk cellbiologi,Per-Ola Carlsson
Jansson, Leif, 1955- (författare)
Uppsala universitet,Institutionen för medicinsk cellbiologi,Leif Jansson
visa fler...
Carlsson, Per-Ola, 1970- (författare)
Uppsala universitet,Institutionen för medicinsk cellbiologi,Medicin,Per-Ola Carlsson
visa färre...
 (creator_code:org_t)
2008-12-18
2009
Engelska.
Ingår i: Endocrinology. - : The Endocrine Society. - 0013-7227 .- 1945-7170. ; 150:4, s. 1646-1653
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Transplantation of pancreatic islets is clinically used to treat type 1 diabetes, but requires multiple donors. Previous experimental studies have demonstrated that transplanted islets have a low blood vessel density, which leads to a hypoxic microenvironment. The present study tested the hypothesis that experimental prolactin pretreatment, a substance which seems to stimulate angiogenesis in endogenous islets, would increase graft blood vessel density, thereby improving transplantation outcome. Pancreatic islets from C57BL/6 mice were incubated with prolactin (500 ng/ml) or vehicle during the last 24 h of culture before syngeneic transplantation beneath the renal capsule, or recipients were injected with prolactin or vehicle for the first 7 days after transplantation. One month post-transplantation, graft vascular density, blood flow, oxygen tension, endocrine volume and function was evaluated. Also human islets were incubated with prolactin or vehicle before experimental transplantation and investigated for vascular engraftment. Vascular engraftment of syngeneically transplanted mouse islets was improved by both in vivo and in vitro prolactin pretreatment. Moreover, prolactin pretreatment in vitro of islets used for transplantation improved recovery from diabetes in a minimal islet mass model. Interestingly, also human islets subjected to prolactin treatment before experimental transplantation demonstrated improved revascularization, blood perfusion and oxygen tension when evaluated one month post-transplantation. We conclude that prolactin may improve engraftment of transplanted pancreatic islets. The protocol with pretreatment of islets ex vivo could minimize the risk of side effects when used in the clinical setting.

Nyckelord

Angiogenesis
Islet graft
Islet of Langerhans
Prolactin
Thrombospondin-1
MEDICINE
MEDICIN
Medical Cell Biology
Medicinsk cellbiologi

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy